ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 108 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 28.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $111,000 | -72.0% | 76,866 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $396,000 | +26.1% | 76,866 | +42.8% | 0.00% | 0.0% |
| Q3 2021 | $314,000 | -33.0% | 53,818 | -7.5% | 0.00% | -33.3% |
| Q2 2021 | $469,000 | +29.9% | 58,170 | +34.1% | 0.00% | +50.0% |
| Q1 2021 | $361,000 | +69.5% | 43,363 | +54.2% | 0.00% | 0.0% |
| Q4 2020 | $213,000 | -28.5% | 28,124 | +0.6% | 0.00% | -33.3% |
| Q3 2020 | $298,000 | -46.0% | 27,963 | -23.2% | 0.00% | -50.0% |
| Q2 2020 | $552,000 | +265.6% | 36,417 | +100.7% | 0.01% | +200.0% |
| Q1 2020 | $151,000 | -40.1% | 18,143 | +22.6% | 0.00% | -33.3% |
| Q4 2019 | $252,000 | +9.1% | 14,793 | +18.8% | 0.00% | -25.0% |
| Q3 2019 | $231,000 | -12.5% | 12,449 | +7.7% | 0.00% | -20.0% |
| Q2 2019 | $264,000 | -12.9% | 11,554 | -19.7% | 0.01% | -16.7% |
| Q1 2019 | $303,000 | +90.6% | 14,392 | +6.2% | 0.01% | +50.0% |
| Q4 2018 | $159,000 | -7.0% | 13,556 | +82.2% | 0.00% | 0.0% |
| Q3 2018 | $171,000 | – | 7,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $49,965,000 | 30.39% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,356,363 | $99,674,000 | 21.44% |
| Selkirk Management LLC | 348,805 | $7,981,000 | 4.29% |
| Trellus Management Company, LLC | 55,502 | $1,270,000 | 1.72% |
| GRIFFIN ASSET MANAGEMENT, INC. | 550,046 | $12,585,000 | 1.60% |
| Belpointe Asset Management LLC | 272,459 | $6,234,000 | 1.23% |
| Cannell & Co. | 1,115,239 | $25,517,000 | 0.97% |
| CHARTIST INC /CA/ | 64,765 | $1,481,823,000 | 0.94% |
| Chicago Capital, LLC | 546,279 | $12,499,000 | 0.80% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,546,000 | 0.76% |